About Red Nucleus
Red Nucleus is a Healthcare company based in Yardley (United States) founded in 2014, and was acquired by Thomas H Lee Partners in October 2024. Advisory, scientific, and medical communications provided for pharmaceutical industry. Red Nucleus has completed 11 acquisitions, including Actando, Bridge Medical and COEUS. Its chief executive, as recorded, is Ian Kelly. Its website rednucleus.com draws about 14 thousand monthly visits. Red Nucleus offers products and services including DirectusPRO, iTakeControl, Partner Vault, Red Nucleus Training Institute, and UNIFY. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity is RED NUCLEUS SOLUTIONS LLC. Its competitors include ANI Pharmaceuticals, Caidya and Aptar; 1 of its 3 listed competitors has raised funding.
Company details
Red Nucleus was founded in 2014 and is based in Yardley, United States. Services are offered in advisory, scientific, and medical communications within the pharmaceutical and biotech sectors. Subject matter experts are provided in areas such as quality, clinical, safety, regulatory, and medical affairs. Operations focus on delivering insights, efficiencies, and support to shape value, navigate market access, and optimize pricing for innovators aiming to enhance health outcomes.
- InvestorsThomas H Lee Partners
& 2 more
- Investments & AcquisitionsActando
& 10 more
- Acquired by
Products & Services of Red Nucleus
Red Nucleus offers a comprehensive portfolio of products and services, including DirectusPRO, iTakeControl, Partner Vault, Red Nucleus Training Institute, and UNIFY.
Platform for managing scientific and advisory services in life sciences.
Tool for interactive learning and development in healthcare contexts.
System for secure storage and access to partner resources.
Institute providing training solutions for life sciences professionals.
Platform unifying game-based learning for healthcare applications.
Lab for creating interactive games to enhance medical education.
Apps and channels of Red Nucleus
its YouTube channel Red Nucleus has 1.23K subscribers and 30 videos.
Videos from Red Nucleus
The most watched videos on Red Nucleus's YouTube channel, Red Nucleus (1.23K subscribers). Click a video to play it here.
More on Red Nucleus.
Funding Insights of Red Nucleus
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Red Nucleus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2016 | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Red Nucleus
Red Nucleus has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Thomas H Lee Partners, Renovus Capital Partners and The Riverside Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| renovuscapital.com | ||||
Private equity and debt are provided to middle market companies. | riversidecompany.com | Cleveland, United States | ||
Private equity investments are directed toward traditional industries. | 1974 | thl.com | Boston, United States |
Investor details for Red Nucleus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Red Nucleus
1 people are tracked at Red Nucleus (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ian Kelly | CEO | Leadership |
Complete people profiles for Red Nucleus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Red Nucleus
Red Nucleus has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Actando, Bridge Medical and COEUS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Evidence and outcomes research services are offered by Bridge Medical for biopharmaceutical companies. | bridgemedical.org | 2011 | Feb 2026 | •••• | ||
Provider of formulations development and consulting services for biopharma sector | 1coeus.com | Devon, United States | 2009 | Feb 2025 | •••• | |
Provider of human agency services | elementh.com | Royal Oak, United States | 2013 | Feb 2023 | •••• | |
Market access and strategy services are provided for pharmaceuticals. | jupiterls.com | Boston, United States | 2015 | Sep 2022 | •••• | |
Learning and decision-making tools are supplied for the pharmaceutical sector. | actando.com | Geneva, Switzerland | 2010 | Jun 2022 | •••• | |
Content creation and market research services are provided to clients. | ortleybio.com | United States | 2019 | Apr 2021 | •••• | |
Business strategy consulting services are provided to clients. | ppmadvisorygroup.com | Chatham, United States | 2017 | Apr 2021 | •••• | |
Provider of SaaS-based compliance, audit, and regulatory management software for life science professionals | itakecontrolhealth.com | Wayne, United States | 2015 | Mar 2021 | •••• | |
Digital Health Marketing and Consulting for global pharmaceutical and medical device industries | invivo.com | Toronto, Canada | 1998 | Sep 2020 | •••• | |
Drug discovery training services are provided to life sciences professionals. | lifesciencetraininginstitute.com | Horsham, United States | 2013 | Sep 2020 | •••• |
Complete acquisition details for Red Nucleus
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Red Nucleus
14 dated milestones of Red Nucleus across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Red Nucleus is founded.
- Funding First funding round.
- Exit Acquired by Riverside.
- Acquisition Acquires Life Science Training Institute.
- Acquisition Acquires INVIVO Communications.
- Acquisition Acquires iTakeControl.
- Acquisition Acquires PPM Advisory Group.
- Acquisition Acquires OrtleyBio.
- Acquisition Acquires Actando.
- Acquisition Acquires Jupiter Life Science Consulting.
- Acquisition Acquires element H.
- Exit Acquired by Thomas H Lee Partners.
- Acquisition Acquires COEUS.
- Acquisition Acquires Bridge Medical.
Competitors of Red Nucleus
Red Nucleus has 3 listed competitors in our database, 1 of them funded. They include ANI Pharmaceuticals, Caidya and Aptar.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anipharmaceuticals.com | 1996 | Baudette, United States | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | ||
| caidya.com | 2003 | Morrisville, United States | $373M | 351 | CRO focused on clinical development for phases II & III clinical trials and regulatory affair services | |
| aptar.com | 1992 | Crystal Lake, United States | 232 | Regulatory support, brand differentiation, and prototyping services are provided. |
Detailed competitors of Red Nucleus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Red Nucleus
The website of Red Nucleus (rednucleus.com) receives about 13.9K visits a month.
- Monthly visits13.9K
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Red Nucleus (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Red Nucleus
Complete news archive for Red Nucleus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Red Nucleus
Red Nucleus was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Red Nucleus is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
Ian Kelly is the CEO of Red Nucleus, as recorded in our data.
Red Nucleus was founded in 2014 and is based in Yardley, United States. Services are offered in advisory, scientific, and medical communications within the pharmaceutical and biotech sectors. Subject matter experts are provided in areas such as quality, clinical, safety, regulatory, and medical affairs. Operations focus on delivering insights, efficiencies, and support to shape value, navigate market access, and optimize pricing for innovators aiming to enhance health outcomes.
Red Nucleus's top competitors include ANI Pharmaceuticals, Aptar and Caidya.
Red Nucleus offers DirectusPRO, iTakeControl, Partner Vault, Red Nucleus Training Institute, and 2 more products and services.
Red Nucleus has made 11 acquisitions, including Actando, Bridge Medical, and COEUS.
Red Nucleus has 3 investors. Key investors include Thomas H Lee Partners, Renovus Capital Partners, and The Riverside Company.
Red Nucleus operates through Red Nucleus Solutions Llc.
Yes. Red Nucleus was acquired by Riverside in March 2020.